Insider · CIK 0001796309

Salzmann Peter

Reports to the SEC for 2 companies · NEW YORK, NY

sec.gov

Transactions

Companies

Filings

CIK

0001796309

Forms 4 and 5

Insider transactions

50 trades

Date	Company	Role	Code	Shares	Price	Value	Shares after
2025-04-16	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,321 sh	$14.89	−$124K	1,178,191
2025-04-09	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−28.1K sh	$12.99	−$365K	1,186,512
2025-04-01	IMVTImmunovant, Inc.A Award	Director, Chief Executive Officer	AAward	+266K sh	—	—	1,214,606
2025-04-01	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+374K sh	—	—	374,395
2025-02-19	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−15.4K sh	$20.86	−$322K	948,786
2025-01-15	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,352 sh	$23.81	−$199K	964,640
2025-01-15	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−415 sh	$24.19	−$10K	964,225
2025-01-08	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,105 sh	$24.10	−$123K	972,992
2024-11-20	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−16.7K sh	$25.45	−$425K	978,097
2024-10-16	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−9,095 sh	$28.79	−$262K	994,789
2024-10-09	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,460 sh	$29.56	−$132K	1,003,884
2024-08-21	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−14.5K sh	$31.84	−$461K	1,008,942
2024-08-21	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−598 sh	$32.32	−$19.3K	1,008,344
2024-07-17	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−8,175 sh	$29.64	−$242K	1,023,922
2024-07-17	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−510 sh	$30.55	−$15.6K	1,023,412
2024-07-09	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,619 sh	$28.06	−$130K	1,032,097
2024-05-30	CRBPCorbus Pharmaceuticals Holdings, Inc.A Award	Director	AAward	+2,783 sh	—	—	2,783
2024-05-22	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−16.2K sh	$29.65	−$479K	1,036,716
2024-05-16	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+2,783 sh	—	—	2,783
2024-04-17	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−26.4K sh	$28.80	−$759K	1,060,593
2024-04-17	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−7,714 sh	$29.94	−$231K	1,052,879
2024-04-09	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,807 sh	$31.18	−$150K	1,086,958
2024-04-02	IMVTImmunovant, Inc.A Award	Director, Chief Executive Officer	AAward	+161K sh	—	—	1,091,765
2024-04-02	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+201K sh	—	—	200,667
2024-02-22	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−13.5K sh	$36.15	−$486K	931,231
2024-01-05	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,824 sh	$38.59	−$148K	944,685
2023-11-22	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−15.6K sh	$32.75	−$511K	949,125
2023-11-22	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−616 sh	$33.52	−$20.6K	948,509
2023-10-05	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−894 sh	$35.54	−$31.8K	969,071
2023-10-05	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,345 sh	$36.39	−$158K	964,726
2023-08-30	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−50.9K sh	$21.97	−$1.12M	975,873
2023-08-30	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−5,908 sh	$22.48	−$133K	969,965
2023-08-14	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−91.7K sh	$21.34	−$1.96M	1,038,053
2023-08-14	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−11.3K sh	$22.04	−$249K	1,026,739
2023-08-07	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−101K sh	$21.73	−$2.2M	1,129,797
2023-07-12	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,233 sh	$19.73	−$63.8K	1,231,136
2023-05-18	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option (right to buy)A Award	Director	AAward	+5,300 sh	—	—	5,300
2023-04-18	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−3,395 sh	$15.27	−$51.8K	1,234,369
2023-04-12	IMVTImmunovant, Inc.A Award	Director, Chief Executive Officer	AAward	+244K sh	—	—	1,237,764
2023-04-12	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+317K sh	—	—	316,585
2023-01-11	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−4,021 sh	$16.80	−$67.6K	993,932
2022-10-13	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−2,793 sh	$9.18	−$25.6K	997,953
2022-09-28	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,605 sh	$4.67	−$7,495.35	1,000,746
2022-08-30	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,644 sh	$5.83	−$9,584.52	1,002,351
2022-08-17	IMVTImmunovant, Inc.A Award	Director, Chief Executive Officer	AAward	+451K sh	—	—	1,003,995
2022-08-17	IMVTImmunovant, Inc. · Stock Option (right to buy)A Award	Director, Chief Executive Officer	AAward	+679K sh	—	—	678,592
2022-07-27	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,528 sh	$4.27	−$6,524.56	552,731
2022-06-29	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,376 sh	$4.02	−$5,531.52	554,259
2022-05-24	IMVTImmunovant, Inc.S Sale	Director, Chief Executive Officer	SSale	−1,471 sh	$3.79	−$5,575.09	555,635
2022-05-18	CRBPCorbus Pharmaceuticals Holdings, Inc. · Stock Option(right to buy)A Award	Director	AAward	+79.6K sh	—	—	79,600

Recent filings

Accepted (ET)
Apr 174
Salzmann Peter0001764013-25-000075
SEC(opens sec.gov)
Apr 114
Salzmann Peter0001764013-25-000066
SEC(opens sec.gov)
Apr 34
Salzmann Peter0001764013-25-000049
SEC(opens sec.gov)
Feb 214
Salzmann Peter0001764013-25-000030
SEC(opens sec.gov)
Jan 174
Salzmann Peter0001764013-25-000013
SEC(opens sec.gov)
Jan 104
Salzmann Peter0001764013-25-000003
SEC(opens sec.gov)
Nov 224
Salzmann Peter0001764013-24-000193
SEC(opens sec.gov)
Oct 184
Salzmann Peter0001764013-24-000174
SEC(opens sec.gov)
Oct 114
Salzmann Peter0001764013-24-000165
SEC(opens sec.gov)
Aug 234
Salzmann Peter0001764013-24-000156
SEC(opens sec.gov)
Jul 194
Salzmann Peter0001764013-24-000133
SEC(opens sec.gov)
Jul 104
Salzmann Peter0001764013-24-000125
SEC(opens sec.gov)
Jun 34
Salzmann Peter0000950170-24-068030
SEC(opens sec.gov)
May 244
Salzmann Peter0001764013-24-000098
SEC(opens sec.gov)
May 204
Salzmann Peter0001209191-24-005676
SEC(opens sec.gov)
Apr 194
Salzmann Peter0001764013-24-000075
SEC(opens sec.gov)

Companies

Address

C/O IMMUNOVANT, INC. 320 W 37TH STREET, 6TH FLOOR

NEW YORK, NY, 10018